19 March 2024 : Original article
Long-Term Outcomes with Prolonged-Release Tacrolimus in Kidney Transplantation: A Retrospective Real-World Data Analysis
Wilfried Gwinner1ABDE*, Swapneel Anaokar2ACDE, Martin Blogg2ACDE, Birgit Hermann3ACDE, Carola del Pilar Repetur2CDE, Mario Schiffer4ABDEDOI: 10.12659/AOT.942167
Ann Transplant 2024; 29:e942167
Table 6 Kaplan-Meier estimates of patient survival stratified by population cohort (first 5 years post-transplant).
| KM rate estimate (95% CI) | Year | Cohort | |||
|---|---|---|---|---|---|
| De novo (n=101) | Early conversion (n=12) | Late conversion (n=50) | Full analysis (N=163) | ||
| Patient survival | 1 | 0.980 (0.923–0.995) | 1.000 (1.000–1.000) | 1.000 (1.000–1.000) | 0.988 (0.952–0.997) |
| 2 | 0.941 (0.873–0.973) | 0.917 (0.539–0.988) | 1.000 (1.000–1.000) | 0.957 (0.912–0.979) | |
| 3 | 0.941 (0.873–0.973) | 0.917 (0.539–0.988) | 1.000 (1.000–1.000) | 0.957 (0.912–0.979) | |
| 4 | 0.921 (0.848–0.960) | 0.917 (0.539–0.988) | 1.000 (1.000–1.000) | 0.945 (0.897–0.971) | |
| 5 | 0.900 (0.823–0.945) | 0.917 (0.539–0.988) | 0.977 (0.846–0.997) | 0.925 (0.872–0.957) | |
| CI – confidence interval; KM – Kaplan-Meier. | |||||